Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Optimi Health Stock News

OPTHFOTCQX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.1317

0.0112.36%

At close: -

$0.1510

0.0214.66%

After Hours: Oct 31, 9:26 AM EDT

Optimi Health (OPTHF) Forecast

News

Earnings Optimi Health (OPTHF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Optimi Health Stock News | OTC:OPTHF | Benzinga

Get the latest news on Optimi Health stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Optimi Health performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, September 16, 2024

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Juan Spínelli

Thursday, June 06, 2024

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia
Rolando García

Wednesday, April 17, 2024

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein

Tuesday, April 09, 2024

Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Lara Goldstein

Tuesday, March 26, 2024

Two Top Biotechs Forge MDMA Supply Deals For An Expanding Research Field
Lara Goldstein

Saturday, March 16, 2024

Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein

Saturday, March 02, 2024

Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Lara Goldstein

Friday, January 26, 2024

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein

Monday, January 08, 2024

Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
Lara Goldstein

Monday, September 11, 2023

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Lara Goldstein

Friday, September 08, 2023

Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
Lara Goldstein

Monday, August 14, 2023

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Lara Goldstein

Tuesday, August 01, 2023

Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
Lara Goldstein

Tuesday, June 20, 2023

Psyched: $75M In Federal Funds, Gov. Polis Opens MAPS Event, CNN's Show, Dock Ellis' LSD Pitch & More
Lara Goldstein
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
Lara Goldstein

Tuesday, May 23, 2023

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
Lara Goldstein

Wednesday, May 17, 2023

The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales
Lara Goldstein

Monday, May 15, 2023

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Lara Goldstein

Thursday, May 11, 2023

Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
Lara Goldstein

Monday, April 03, 2023

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
Javier Hasse

Tuesday, March 07, 2023

Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Lara Goldstein

Monday, March 06, 2023

Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
Lara Goldstein

Thursday, March 02, 2023

Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California
Lara Goldstein

Monday, February 13, 2023

Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Lara Goldstein

Thursday, February 09, 2023

How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
Lara Goldstein

Monday, February 06, 2023

MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Lara Goldstein

Wednesday, January 25, 2023

Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Lara Goldstein

Saturday, January 21, 2023

Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Lara Goldstein

Thursday, October 20, 2022

Canada Update: Psychedelics Legal Landscape, Overview & Near-Term Predictions
Lara Goldstein

Tuesday, October 11, 2022

Optimi Closes Non-Brokered Private Placement, Here Are The Details
Lara Goldstein

Thursday, September 22, 2022

Two Psychedelics Companies Will Study Effects Of Natural Psilocybin And MDMA In Healthy Volunteers
Lara Goldstein

Wednesday, September 07, 2022

Psychedelic Mushrooms Are Going Global: Supply Deal With UK-Based Wellness Company Moves Forward
Lara Goldstein

Friday, September 02, 2022

New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
Lara Goldstein

Thursday, September 01, 2022

Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics
Lara Goldstein

Tuesday, August 30, 2022

First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details
Joana Scopel

Tuesday, August 16, 2022

Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead
Lara Goldstein

Wednesday, August 10, 2022

Meet Blue Serenity, Canada's First Natural Therapeutic Psilocybin Product For Approved Patients
Lara Goldstein

Monday, August 08, 2022

What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
Lara Goldstein

Wednesday, July 13, 2022

New Optimi Supply Agreement: Psilocybin For Phase 1 Trial On Microdosing For Wellbeing, No Hallucinogenic Effects
Lara Goldstein

Tuesday, June 28, 2022

HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
Lara Goldstein

Wednesday, June 15, 2022

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Natan Ponieman

Wednesday, June 08, 2022

Shrooms Move Forward For Palliative Care, Optimi To Supply High-Grade Psilocybin For Private Mental Health Practitioner In CA
Lara Goldstein

Tuesday, May 31, 2022

Optimi Health Signs Two New Supply Agreements In Less Than a Week
Lara Goldstein

Wednesday, May 25, 2022

Optimi Completes First Grow of Psilocybin Mushrooms, Introduces New Head Of Cultivation
Lara Goldstein
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
Natan Ponieman

Wednesday, May 18, 2022

Optimi Health Adds Large Portfolio Of Magic Mushrooms Strains To Its Genetic Bank
Fermin Orgambide

Monday, October 18, 2021

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman

Wednesday, October 13, 2021

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved